| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse events of hepatic function disorder in Japanese patients with radically unresectable or metastatic renal cell carcinoma treated with pembrolizumab plus axitinib: a post-marketing surveillance study
|
Oya, Mototsugu
|
|
|
30 |
6 |
p. 1229-1236
|
artikel
|
| 2 |
A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study
|
Aoyama, Toru
|
|
|
30 |
6 |
p. 1162-1173
|
artikel
|
| 3 |
Comparison of the prognostic effect of taxane regimens combined with ramucirumab before nivolumab for advanced gastric cancer
|
Kikuchi, Yoshinori
|
|
|
30 |
6 |
p. 1152-1161
|
artikel
|
| 4 |
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer
|
Onaga, Ryutaro
|
|
|
30 |
6 |
p. 1143-1151
|
artikel
|
| 5 |
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data
|
Ueki, Yushi
|
|
|
30 |
6 |
p. 1136-1142
|
artikel
|
| 6 |
Conditions for effective use of liposomal irinotecan with fluorouracil and leucovorin in unresectable pancreatic cancer after FOLFIRINOX treatment
|
Okada, Yasuyuki
|
|
|
30 |
6 |
p. 1201-1210
|
artikel
|
| 7 |
Correction: The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis
|
Xu, Ke
|
|
|
30 |
6 |
p. 1258
|
artikel
|
| 8 |
Efficacy and safety of cancer vaccine therapy in malignant melanoma: a systematic review
|
Seta, Takeshi
|
|
|
30 |
6 |
p. 1080-1097
|
artikel
|
| 9 |
Efficacy and safety of postoperative adjuvant chemotherapy with oxaliplatin for elderly patients: results from the CCOG-1302 study
|
Umeda, Shinichi
|
|
|
30 |
6 |
p. 1174-1182
|
artikel
|
| 10 |
Evaluation of drug lag and drug loss in Japan: participation in global phase III oncology trials
|
Shiga, Kaname
|
|
|
30 |
6 |
p. 1109-1117
|
artikel
|
| 11 |
Genomic landscape of biliary tract cancer and corresponding targeted treatment strategies
|
Yamada, Daisaku
|
|
|
30 |
6 |
p. 1069-1079
|
artikel
|
| 12 |
Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study
|
Kano, Satoshi
|
|
|
30 |
6 |
p. 1127-1135
|
artikel
|
| 13 |
Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study
|
Iizuka, Yusuke
|
|
|
30 |
6 |
p. 1211-1217
|
artikel
|
| 14 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of amivantamab plus lazertinib for non-small cell lung cancer, durvalumab for small cell lung cancer, tislelizumab for esophageal cancer, tisotumab vedotin for cervical cancer, ivosidenib for leukemia, and venetoclax for lymphoma in Japan
|
Matsumura, Noriomi
|
|
|
30 |
6 |
p. 1049-1050
|
artikel
|
| 15 |
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)
|
Tanabe, Kenji
|
|
|
30 |
6 |
p. 1237-1246
|
artikel
|
| 16 |
Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study
|
Kobayashi, Kazuki
|
|
|
30 |
6 |
p. 1218-1228
|
artikel
|
| 17 |
Prognostic prediction using recursive partitioning analysis of patients undergoing salvage surgery for locally recurrent oral squamous cell carcinoma
|
Sakai, Toshihiko
|
|
|
30 |
6 |
p. 1118-1126
|
artikel
|
| 18 |
Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors
|
Kobayashi, Shogo
|
|
|
30 |
6 |
p. 1060-1068
|
artikel
|
| 19 |
Safety of laparoscopic surgery for ovarian tissue cryopreservation in pediatric patients
|
Kondo, Haruhiro
|
|
|
30 |
6 |
p. 1051-1059
|
artikel
|
| 20 |
Serum amylase level as a predictive biomarker for persistent grade 1 chemotherapy-associated oral mucositis: a retrospective cross-sectional study
|
Ozdemir, Nursema
|
|
|
30 |
6 |
p. 1098-1108
|
artikel
|
| 21 |
Simple definition of biologically borderline resectable colorectal liver metastases based on early surgical failure
|
Furukawa, Kenei
|
|
|
30 |
6 |
p. 1193-1200
|
artikel
|
| 22 |
Survival paradox and effect of adjuvant chemotherapy for high-risk Stage II and low-risk Stage III colorectal cancer
|
Noda, Keisuke
|
|
|
30 |
6 |
p. 1183-1192
|
artikel
|
| 23 |
Utility of circulating human papillomavirus DNA as a biomarker for detection and prognosis of cervical cancer in Japanese patients
|
Taguchi, Tomoko
|
|
|
30 |
6 |
p. 1247-1257
|
artikel
|
Tijdschrift beschrijving